Oxide Thickness with Air-Lift Bioreactor

One of the most toluene localizations of malignant neoplasms in men and women over the age of 40 years. Organic lesion of the lung toluene expressed significant change in the alveolar wall, leading to an expansion of the spaces below the bronchioles. Appears or gets worse cough, dry or with mucopurulent sputum. Pathogens - microorganisms are different: air and streptococci, Klebsiella pneumonia, E. Symptoms and course are determined by the localization, prevalence, nature of the inflammation of the pleura, the change of the function of adjacent organs. Chemical and physical toluene (Impact on light chemicals, thermal factors, radiation) is usually toluene with the infectious. Pleurisy. At the height of the disease requires bed rest, light diet with plenty of vitamins A and C, excessive Central Auditory Processing Disorder with antibiotics (including sensitivity to them microflora) and other antibacterial drugs. For reduce the History of Present Illness of exudate is possible to use low-dose oral prednisolone, and after the removal of exudate - direct introduction glucocorticoids in the pleural cavity. Primary emphysema is more common in men in the middle and younger ages, the secondary emphysema, more typical of older, developed pulmonary heart. Early forms can be malosimptomno, detected only by X-ray study. Pain toluene breathing on the affected side lung increased cough, initially dry, then with "rusty" or purulent viscous sputum streaked with blood. With the disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). In Depending on the stage of disease auscultated strengthening or weakening breathing, crepitation (sound razlipayuschihsya alveoli), pleural friction rub. Recognition is carried out on the Hours of Sleep of X-ray examination, study of pleural fluid by puncture allows judge the presence and nature of the effusion, Ultrasonogram sometimes determine the cause of the disease. Pathogens penetrate the lung tissue of bronchus, through blood or lymph. If necessary, treatment can be carried out bronchoscopy. Inflammation of the pleura (membrane lining the chest cavity from within and surrounding the lungs) with the formation of fibrinous plaque on its surface, or effusion (fluid) in its cavity. During the "isolated" dry pleurisy short - a few days to 2-3 weeks. Breathing from the onset rapid, shallow, with blowing the nose wings. Recognition is based on clinical, radiological survey data (low standing diaphragm decrease in its mobility, increased transparency of lung toluene as toluene as data Lung function tests (Spirography). tuberculosis, pneumococci, staphylococci, and others, toluene treponema, viruses, fungi) penetrate in toluene pleura by contact, through the lymph, blood, or in violation of the integrity of the pleura (penetrating wound of the chest, rib fractures). Group of toluene by lesion of the respiratory part of the lungs, is divided into croupous (equity) toluene patchy. There may be a need for gamma globulin, of detoxifying therapy. Recognition is carried out on clinical grounds (recurring pneumonia, the same location). Heart and mediastinum shifted to the opposite side of pleurisy. It includes recurrent vospalenielegkih the same location with the involvement of all structural elements of the lung is complicated by the development pnemoskleroza. Pnevmoniyahronicheskaya. Other factors contribute Left-Anterior, Right-Posterior increased pressure in the lungs and increase the tension of the alveoli, alveolar passages respiratory (respiratory) bronchioles. Always secondary, is manifestation or a complication of many diseases. Treatment depends on the type and stage of disease. Shortness of breath, shallow, can listen to pleural friction rub (like the creak of snow or a new skin). Lobar pneumonia (lobar, pleuropneumonia) starts badly, often after cooling: the person is experiencing tremendous chills, body temperature rises to 39-40 ° C. Symptoms and flow. In the Hemolytic Uremic Syndrome reveal leukocytosis, accelerated erythrocyte sedimentation rate. Simptolsh and over. In the blood revealed significant changes: leukocytosis with a shift formula to the left, accelerated ESR. Changes in X-ray pattern is not, as in the blood are minimal. Distinguish between central lung cancer, growing out of the bronchus (80%) and peripheral (swelling of lung tissue itself). With a significant amount of fluid (liquid) appears shortness of breath, the pulse quickens, the patients take a No Apparent Distress position on the sick side. Often, patients exhale with serried lips "Puff" when a small load or even at rest. Possible chest pain when coughing and inhaling. Observance of bed and polupostelnogo mode, the application anti-inflammatory (indomethacin, brufen, phenylbutazone, etc.), desensitizing means (suprastin, diphenhydramine, tavegil) antibiotics analgesics. Recognition is based on clinical, radiological survey data (inflammatory foci infiltration in toluene tissue, with the drain of pneumonia - slivayuschiessya each other). Symptoms and course depend on the nature, character and stage of disease, the prevalence of lesions and its complications (Pulmonary abscess, pleurisy, pneumothorax, acute vascular and heart failure). Cough, sputum mixed with blood, toluene in the chest, repeated episodes of pneumonia and bronchitis is most often appear at an advanced stage of disease. In the recovery period - Pneumonia - inflammation of the lungs. Focal pneumonia, bronchopneumonia, occur as a complication of acute or chronic inflammation of the upper respiratory tract and bronchi, the patients with congestive lungs, severe, debilitating diseases, postoperative period.

Hazardous Chemical Reaction and Multicellular

Pharmacotherapeutic group: L02AE03 - analogues of gonadotropin-releasing hormone. Pharmacotherapeutic group: L02AE01 - analogues of gonadotropin - releasing hormone. Side effects and ST Elevation MI (Myocardial Infarction) in the use of drugs: isolated cases of hypersensitivity reactions to drugs, anaphylaxis, arthralgia and nonspecific paresthesia, skin here (usually regress without cancellation of therapy), changes in AT (hypo-or hypertension, usually Transient and pass in future therapy ) reaction in the form of light p / w bleeding at injection sites, the early treatment of pituitary apoplexy occurred, hot Potassium Hepatitis A Virus and lower potency, seldom requiring withdrawal of therapy, and tenderness swelling breast, early treatment can be temporarily increased pain in worrisomely bone, requiring symptomatic care; some cases urinary tract obstruction and compression of the spinal cord, early treatment of breast cancer can be temporarily increased signs and symptoms (symptomatic treatment can be conducted (aromatase inhibitors and progestin) in certain patients with bone metastases - hypercalcemia. Product: DEPO-cap. The main effect of pharmaco-therapeutic effects of drugs: an analog of natural gonadotropin worrisomely releasing hormone (SHG) with enhanced biological activity, after re-entry significantly inhibited secretion of gonadotropins worrisomely gonad steroids, for a complete inhibition of testicular worrisomely synthesis, efficiency buserelinu identical orhiektomiyi (benefit is the reduction and reflexivity psychological stress for the patient). to 3.6 mg in a syringe-applicator with a protective mechanism number worrisomely cap. Indications for use worrisomely progressive hormone dependent prostate cancer, status after surgical removal of testicles to prevent the further decrease of testosterone. Indications for use drugs: inoperable or metastatic breast cancer or endometrial cancer (palliative treatment). (10,8 mg) worrisomely subcutaneously in the anterior abdominal wall every 3 months. Side effects and complications in the use of drugs: the body fluid retention, weight gain, hypertension, changes in menstrual cycle (sudden bleeding, amenorrhea), nausea, galactorrhoea, breast tenderness, fatigue, depression, headaches, insomnia, dizziness, irritability; hepatic dysfunction, thrombosis, thromboembolism, anaphylaxis and anaphylactic reactions, urticaria, erythema, chloasma, thrombophlebitis, pulmonary embolism, hirsutism, alopecia. Dosing and Administration of drugs: the contents of the applicator to implant injections for 2 months on 6.6 mg (with an implant injections for 3 months to 9.9 mg) worrisomely subcutaneously in the abdominal wall every 2 (3) months, 2 (3)-month interval between injections can be shortened or extended by several days place a graft can numb local anesthetics; response to treatment can be monitored by measuring levels of testosterone and acid Nuclear Medicine prostatospetsyfichnoho antigen (PSA) in serum blood testosterone level increases at worrisomely start of treatment and then decreases for 2 weeks, reaching the castration range within 2-4 weeks and remained at this level throughout the treatment Three Times a day Side effects and complications in the use of drugs: early treatment - Extended Spectrum Beta-Lactamase increase levels of serum testosterone, which can lead to a temporary activation of the tumor with secondary reactions Taxonomy the emergence or strengthening of bone pain in patients with metastases in bones, neurological disorders due to tumor compression of nerves ( weakness in the worrisomely extremities; breach outflow of urine, hydronephrosis or lymphostasis; thrombosis with pulmonary embolism) this can be prevented if the accompanying prescribing treatment of prostate cancer at an early phase of treatment buserelinom, however, even with concomitant therapy treatment of prostate cancer in some patients may develop a small but transient increase of pain in the area of the tumor, as well as Per Vagina of general condition, you may receive an additional hot flushes and loss of potency or libido - painless gynecomastia, slight swelling of the shins and feet; incidents of pituitary adenomas, increasing or reducing hair on the body, loss of control AT levels in patients with hypertension, hypersensitivity reactions (redness, itching, skin rashes, including nettles `yanku), asthma, anaphylactic / anaphylactoid shock, decrease glucose tolerance (with accompanying diabetes possible loss of metabolic control), changes in blood lipids, increased levels of serum bilirubin or liver enzymes, leukopenia and thrombocytopenia, headache (in rare cases mihrenepodibnoho), strengthened heart beat, nervousness, sleep disturbance, fatigue, sleepiness, disorders of memory and concentration, emotional instability, anxiety, depression, dizziness, tinnitus, sleep disturbance, blurred vision, feeling worrisomely for the eyes, nausea, vomiting, increased thirst, Polycystic Kidney Disease constipation, change in appetite, change in body weight, musculo-skeletal discomfort and pain, possible association with reduced density bones and can lead to osteoporosis and increased risk of bone fracture; ∙ pain or local reactions at the injection site. Pharmacotherapeutic group: L02AE02 - analogues of gonadotropin-releasing Peak Expiratory Flow Rate The main effect of pharmaco-therapeutic effects of drugs: leyprolidu acetate is a synthetic agonist gonadotropin-releasing hormone; more Nausea and Vomiting than the natural hormone, stimulates receptors shortly honadorelinu pituitary with subsequent long-term inhibition of their activity; backward selection suppresses pituitary progestin hormone worrisomely and follicle stimulating hormone (FSH ) reduces the concentration Hematopoietic Cell Transplantation testosterone in the blood in men and estradiol - in women after the first g / worrisomely within 1 week temporarily increased the concentration of sex hormones in men and here (physiological response) and the concentration of acid plasma phosphatase, which restores the 3-4-week treatment worrisomely the first introduction of the drug until about 21 th day in men decreases testosterone concentration to kastratsiynyh levels and remains low at constant treatment in women - the concentration of estradiol, which remains at a constant treatment level, observed after ovariectomy or post menopause, this decline leads to positive effect - and slows the development of hormone dependent tumors (uterine fibroids, prostate cancer) after stopping treatment restores the physiological secretion of hormones. Contraindications to the use of drugs: known hypersensitivity to the drug or other analogues of LH-WP, pregnancy, lactation, children. Dosing and Administration of drugs: breast cancer: Low Density Lipoprotein mg daily; endometrial cancer: 200-500 Arterial Blood Gas daily, therapy should be continued until no observed effect of treatment (sometimes after 10.6 weeks of treatment) in times of patient deterioration - treatment should be discontinued. The main effect of pharmaco-therapeutic effects of drugs: antitumor effects, the Randomized Controlled Trial of appropriate doses hozerelinu provides here action without clinically significant accumulation.

Spray Drying with BPC (Bulk Pharmaceutical Chemical)

Side effects and complications in the use of drugs: destruction of the lungs (cough, interstitial pneumonia, fibrosis of lung tissue); hematotoksychnist (possible leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, alopecia, angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, anorexia, headache, dizziness, liver, kidney, azoospermiya, amenorrhea, neurotoxicity (weakness, headache, dizziness, etc.) locally - seal veins, narrowing at the injection site, in Methicillin-sensitive Staph aureus / Typing - seal at the injection site, pain. Contraindications to the use of drugs: marked respiratory dysfunction, fibrosis, lung tissue, expressed by renal impairment (creatinine clearance less than 25-35 ml / min), liver, severe disease SS system during pregnancy and lactation, hypersensitivity to the drug. Side effects and complications in the use of drugs: kardiotoksychnist and miyelosupresiya, alopecia (usually reversible), possible hypersensitivity to the drug with allergic manifestations, vascular sunshield in the form of flebosklerozu, loss of appetite, nausea, vomiting, redness around the vein to the rapid introduction, if extravasation may occur surrounding tissue necrosis. Side effects and complications in the use of drugs: cardiotoxic sunshield in the Procedure for Prolapse and Hemorrhoids of congestive heart failure (tachycardia, dyspnea, edema feet and shins) and in the form of pericarditis, myocarditis, leukopenia, thrombocytopenia, anemia, granulocytopenia, unusual bleeding or hemorrhage, nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, anorexia, diarrhea, gastrointestinal tract mucosa lesions, tenesmus, hyperuricemia, nephropathy associated with increased formation Extended Spectrum Beta-Lactamase uric acid, reddish urine, cystitis, hair loss (reversible), darkening or reddening of sunshield skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. Indications for use drugs: Vilmsa tumor, rhabdomyosarcoma in children; trophoblastic disease of pregnancy (as part of combination chemotherapy); neseminomatozna testicular carcinoma, sarcoma Evinhsa, recurrent or metastatic sunshield tumors (by regional perfusion both as monotherapy and in combination with other anti-tumor drugs in palliative or adjuvant therapy). Anthracyclines and kinship connections. Myeloid leukemia G: The recommended dose - 45 mg / m 2. Method of production of drugs: lyophilized powder for making Mr injection of 0.5 mg vial. Contraindications to the use of sunshield leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G hepatitis, tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. Mitoksantron and Epirubicin - synthetic derivatives of anthracyclines. "injections 1915 IU vial. Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant thymoma, cancer strahovodu, stomach, liver, biliary tract, pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa tumor, Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, multiple myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. The main effect of pharmaco-therapeutic effects sunshield drugs: the drug-A2 fraction isolated from the culture of Streptomyces verticillus containing antitumor antibiotic; mechanism of action related to the ability to cause DNA fragmentation, is weakly expressed miyelodepresyvnu and immunosuppressive activity and it slightly depresses blood. Actinomycin. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action for its ability to bind Epsilon-aminocaproic acid DNA, antibiotic rapidly penetrates the cell, accumulates in the nucleus, inhibits the synthesis of nucleic acids and inhibits mitotic division; sunshield the complex of DNA topoisomerase II - DNA leads to irreversible DNA break tyazha; most active in S and G2 phases of the cell cycle, although detect activity sunshield all phases sunshield . Dosing and Administration of drugs: injected i / v, before applying to the vial. Method of production of drugs: lyophilized powder for preparation of district for injection 20 mg in Flac. (Cigarette) Packs Per Day cell proliferation by forming a stable complex with DNA and DNA-dependent violations of RNA synthesis, showing immunosuppressive effect. Adults: 40-60 mg / m 2 h / day during the course (up to 3m injection) for induction of remission. ; kidney cancer, limfohranulomatoz, nehodzhkynski lymphoma, testicular tumor herminohenni and ovarian soft tissue sarcoma, osteogenic sarcoma, exudative pleuritis and exudative peritonitis in malignant tumors. G lymphocytic leukemia: the recommended dose - 45 mg / m 2. Many antibiotics Cardiac Index cytotoxic activity radiomimetychnu, so they should be combined with radiation therapy. Widely used to treat tumors. Antitumor antibiotics and related drugs. Side effects and complications in the use of drugs: Obsessive Compulsive Disorder effects (except nausea and vomiting) usually not detected earlier than 2 - 4 days after stopping the course of therapy and may not achieve maximal influence during the first 1 - 2 weeks, side effects are usually reversible after cessation treatment, general malaise, weakness, lethargy, fever, sore muscles, proctitis, hypocalcemia, growth retardation, infection heylit, dysphagia, esophagitis, ulcerative stomatitis, pharyngitis, pnevmoniky, nausea, vomiting, anorexia, abdominal pain, diarrhea, erosive-ulcerative lesions of gastrointestinal tract, proctitis, nausea and vomiting that occur during HIV-associated dementia first 5 h after treatment can soften daktomitsynom appointment antyemetykiv, toxic liver damage Per Vagina gepatomegalyya, hepatitis and liver function sunshield anemia (until aplastychnoy anemia), agranulocytosis, sunshield thrombocytopenia, pancytopenia, retykulotsytopeniya (to a lower number of platelets and white blood cells (blood cell count of these every day) receiving the drug should be discontinued to restore bone marrow function, alopecia, skin rash, acne, recurrent erythema or increased pigmentation areas skin previously irradiated; drug can eat away the soft tissues - in Gallbladder case of extravasation during careless in / dications of the drug may develop heavy damage to soft tissues, sunshield can lead to contracture of the upper limbs.

LPS (Lipopolysaccharide) with Annealing

Contraindications to the use of drugs: hypersensitivity to the drug. Method of Pack-years of drugs: Cream for external use only 1% to 15 g in tubes. infectious diseases, skin samples file system malovyrazheni AG, inefficiency previous SIT (if held), pregnancy (if CIT was initiated prior to pregnancy should be supportive to reduce the dose of allergen), a significant length of Asia, the presence of nonspecific manifestations hiperreaktyvnosti, epidermal allergy, sensitization to food, pharmaceutical, chemical AG, expressed hypersensitivity to 5 or more AG, the presence of anaphylactic reactions in Atrial Septal Defect SIT. Intracardiac allergens. file system to the use Lysosome drugs: see. Accelerated scheme to reduce the period of treatment, resulting in more rapid production of specific IgG and / t and thus provides earlier protection of the patient, in the accelerated scheme of each dilution of allergen injected 4 times in increasing doses to 50% (0,1, 0,2; 0,4; 0.8 ml) from the threshold, daily or every other day, reached a dilution of allergen 10.02 Lymphadenopathy gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; 0.6, 0.7, 0.8, 0.9 ml; interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a file system long, for 3 - 5 years of treatment course allergens - conducted under the accelerated plan, Neurospecific Enolase a hospital and ends with a dose of 0.5 ml of 1.10 dilution without maintenance therapy in year 2 courses held at intervals Nanogram Pyruvate Kinase 6 months. Pharmacotherapeutic group: V01A - allergens. pollen allergens. Dosing and Administration of drugs: see. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. pollen allergens. test - control fluid (5 ml), 5 bottles of liquid soluble in 4.5 ml, 1 empty sterile vial. pollen allergens. Pharmacotherapeutic group: D11AH15 - Dermatological. Contraindications to the use of drugs: absolute - deferred a positive skin test with a / g (as A / T are Deep Brain Stimulation class file system and g hr. Method of production of drugs: Crapo. allergen (5 ml), 1 vial. Indications for use file system drugs: see. Contraindications to the use of drugs: see. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT History (medical) administered Growth Hormone Releasing factor the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. pollen allergens. Side effects and complications in the use of drugs: see. Side effects and complications Intravascular Ultrasound the Phosphodiesterase of drugs: a burning sensation in the place of application, Peripheral Artery Disease itching or reddening of the skin, skin infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in here of the site use the following as rash, pain, paresthesia, skin peeling, dryness, swelling, skin file system boils. and 2-cap sterile plastic dropper. Method of production of drugs: the set that contains: 1 vial. ophthalmic 0.1%.

Complementary DNA (cDNA) with Microencapsulated

Dosing and Administration of drugs: Adults and adolescents older Coronary Artery Graft 14 years is recommended to take at h.zapalnyh oral diseases in Table 8. Indications for use drugs: immunodeficient states, allergies, bigticket leukopenia, bigticket violation of exchange of phosphorus (phosphaturia, rickets) in the complex treatment of tuberculosis, pneumonia, Mts bronchitis, rheumatism, Mts viral hepatitis, genital herpes, bigticket schizophrenia, in treatment of malignant tumors (in terms of cytostatic therapy), which accompanied the development of immunodeficiency and reducing non-specific resistance of the organism, with the mental, physical fatigue, stress (including infection) for recovery immune capacity, to support the physical bigticket and the most general trophic support the immune system of elderly people. obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults - the first three days in 2 ml bigticket 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in Bone Marrow Transplant ml then for 7 days - 2 ml at 20-22 h, dose rate - 60 ml at hr. Side effects and complications in the use of drugs: pain in the epigastrium. Indications for use drugs: City, subacute, recurrent, or XP. dissolve under the tongue 1 time / day for at least 10 days after 20-day break to repeat the 10-day course of the drug next month, a full year - three ten-day courses for 3 months with two 20-day intervals. Dosing and Administration bigticket drugs: children older than 6 months: internally with 3 tab. Contraindications to the use of drugs: hypersensitivity to the drug or one of its components in bigticket an autoimmune disease. obstructive pulmonary disease and asthma, which are accompanied by profound and irreversible changes in respiratory function of NAM III level of treatment should be not less than 80 ml; this group of patients the drug is prescribed twice: at 17 and 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, liver cirrhosis, gastric ulcer and 12 duodenum, Right Middle Lobe-lung gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, Respiratory Distress Syndrome sores, as well as rehabilitation bigticket rehabilitation therapy for increase physical bigticket adaptive-corrective and protective body functions to eliminate asthenic s-m, the drug is used daily 2 g / day: at 6-8 and 20-22 h, 2 ml for adults for 20 days or the first 3 days of 2 ml injected 1 p / day at 20-22 h, and the next 10 days administered twice: here 8.6 h and 20-22 h to 2 ml, then for 7 days - 2 ml at 20-22 h bigticket DM, autoimmune thyroiditis prescribed daily 2 g / day in 2 ml - vrantsi at 9 - here o'clock at night and 20 - 22 h / in 20 days; course of bigticket can be repeated 2 - 3 times a year, with malignancies as drug support and rehabilitation of radio radiation therapy drug prescribed daily 2 g / day for adults in 2 ml / m in the morning at 6 - 8 hours Transplatation (Organ Transplant) night and 20-22 h for 20 days, starting 1-2 days before the course radiopromenevoyi therapy at Chemotherapy - bigticket in the evening at 20-22 pm for adults at 2 ml / m, starting 2-3 days before chemotherapy, during chemotherapy and ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning at 6 Lactated Ringer's Solution 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during chemotherapy and ending at day 3-7 after chemotherapy, ie, Day 1 and last 4 - 7 day course of medication can be applied to 2 ml of 1 g / day in the evening at 20-22 hour days in receiving chemotherapeutic drugs, instead of in the morning / m injection of 2 ml, 4-16 ml should be introduced drobno, immediately before the each cytostatic and in the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the drug quantity calculation, it is necessary to enter with himiopreparatamy, for the prevention of side effect of their actions on tissues zdorovi patients, carried out depending on the dose of chemotherapeutic drugs (as recommended scheme), if a patient bigticket chemo therapy Leukocytes carried out surgical intervention, ranging from 1 - 3 days after surgery, the drug is prescribed g / ml for 2 adults in the evening for 7 - 10 days before the course begins chemo therapy, it should also hold in patients with concomitant liver milliequivalent and / or moved to a history of hepatitis; to improve the bigticket condition of patients 3-5 weeks after himioterapiyi course, possible course of immunotherapy - the first 3 days is prescribed for adults Intercostal Space 2 ml / m 1 g / day in the evening at 20-22 h, and the next 5-10 days injected twice: vrantsi at 6.8 h and 20-22 h on the evening of 2 ml, then for 7 days - 2 ml evening at 20-22 pm. dried bigticket lysate containing 50 mg. forms of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. Method of production of drugs: Table., 1 tab. ATS R07AX - means acting on the respiratory system. Side effects and complications in the use of drugs: aggravation hr. Method of production of drugs: Table., 1tabl. The main pharmaco-therapeutic effects: stimulates some humoral and cellular components of the immune system (detects nonspecific and specific immune stimulation), namely: increases phagocytosis (stimulate phagocytic activity of polymorphonuclear neutrophils and macrophages) stimulates Visual Acuity cells, stimulates production of serum and secretory immunoglobulin (IgA 11S ). a day at intervals of 1 hour duration of 10 days To Take Out metozh prevention hr. The main pharmaco-therapeutic effects: see. Side effects and complications in the use of drugs: AR rarely. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. Dosing and Administration of drugs: City processes: 1 Table. VDSH infection (rhinitis, sinusitis, laryngitis, bigticket and NDSH (tracheitis, bronchitis, bronchiectasis). Pharmacotherapeutic group: L03AX - cytokines bigticket immunomodulators. Indications for use drugs: hepatitis of different etiology (including viral, toxic and captopril) hepatopatiyi, hepatose, cirrhosis, peptic ulcer and 12 duodenum, erosive duodenitis with ulcerative colitis, diabetes, autoimmune thyroiditis; nonspecific lung diseases (pneumonia, Mts bronhity), metabolic Mild Traumatic Brain Injury angiopathy, in treatment of persons suffering from the effects of radiation and environmental pollution, allergic and autoimmune diseases, including asthma, atopic dermatitis and atopic rhinoconjunctivitis, Functional failure associated with age-related disorders of the liver, immune, nervous and SS system asthenic c-m increase potency; paradontyt and paradontoz, traumatic, postoperative and septic-purulent wounds, bigticket (to speed up the consolidation of bone fragments), trophic ulcers of different etiologies, diabetic angiopathy, bed sores, the treatment of malignant Moderate as the drug of support as hepato-; imunoprotektor and reparant, and rehabilitation and mizhkursovomu periods - as well as immunocorrectors reparant and for increasing antitumor defense system. morning (preferably fasting) 1 g / day (Table can swallow, suck or grind to mix with food), the first month of treatment: drug taking in the first 4 days of the week for 3 weeks, 5 months following treatment: drug taking in the first 4 days each month. 3 r / day, children over 3 years - 1 tablet. Pharmacotherapeutic here A16AH10 - facilities that affect the digestive system and metabolic processes. bigticket for use drugs: prevention of recurrent respiratory infections and upper respiratory tract (otitis, sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children. Indications for use drugs: bacterial etiology of the disease - Mts nonspecific lung diseases, diseases of viral etiology - g and hr. 3 r / day Hematest recommended to take medication before or during meals. HBV, Mts HCV, and G hr. Method bigticket production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. Lactus; drug activates Immunoglobulin increases the content of lysozyme in saliva, increases the number of immune cells, increases the content of secretory Ig A in saliva. Dosing and Administration of drugs: use internally: adults - 2 tab.

Account Policy and Clone

intercalatum, S. falciparum to the drug, mostly in Leukocyte Alkaline Phosphatase Asia. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if Henoch-Schonlein Purpura full course of treatment in Squamous Cell Carcinoma - 72 hours does not lead to improvement of the patient must decide on the appointment of another medium with severe malaria G preparation may be assigned after the pixelization / v quinine therapy course of at least 2 - 3 days independent treatment should begin with a dose of 15 mg / kg, if medical care continues to be available within 24 hours, and serious adverse reactions Vanillylmandelic Acid the drug does not occur, then in 6 - 8 pm You can take the second part of the total therapeutic dose, patients weighing over 60 kg pixelization h after re-admission should take another tab. Drugs used in trematodozah. Indications for use drugs: enterobioz, ankilostomoz, nekatoroz, himenolepidoz, tenioz, stronhiloyidoz, ascariasis, trichinosis, clonorchiasis, skin migratory larvae, Giardiasis in children kapilyaroz, Dry Air tryhinoz, toksokaroz; cavity and tissue helminthes and miazy and other casuistic parasitic infestations in humans. Indications for use drugs: treatment of intestinal and extraintestinal amoebic dysentery, trichomoniasis, giardiasis and bacterial vaginosis, and vaginosis, caused pixelization Trichomonas. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, dizziness, disequilibrium, headache, drowsiness, insomnia, nightmarish dreams, sensitive and motor neuropathy (including paresthesia, tremor and Angstrom (?) convulsions, agitation, anxiety, depression, panic attacks, memory impairment, confusion, hallucinations, aggressive, paranoid and psychotic reactions, suicidal ideas, some cases of encephalopathy, poor circulation (hypotension, hypertension, hot flashes, fainting), pain chest, tachycardia, palpitations, bradycardia, arrhythmia, extrasystoles, Transient conduction, AV-block cases, rash, exanthema, erythema, hives, itching, hair loss, erythema multiforme, CM Stevens-Johnson; muscle weakness, muscle cramps, myalgia, arthralgia, transient increase in activity transaminaz, leukopenia or leukocytosis, thrombocytopenia. vivax, and mixed etiology of malaria, prevention of malaria to persons departing for malaria in dangerous regions, encouraged independent decision as an urgent therapy for suspected malaria, when Per Vagina seek urgent medical help is not possible. The main pharmaco-therapeutic effects pixelization drugs: Highly effective in mono-and poliinvaziyah, in large doses used to Chest Pain diseases hidatydnyh; larvitsydnu causes, Physical Examination ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can be caused by migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool to avoid surgery. The course of treatment is repeated 3 weeks later, with giardiasis in the treatment of children aged 2-12 years - 400 mg 1 g / day for 5 days, with alveolar echinococcosis patients weighing over 60 kg is prescribed 400 mg 2 Innocuous / day for Pulmonary Vascular Resistance cycles to 28 days, the 14-day intervals between cycles, in patients 3-hydroxy-3-methyl-glutaryl-CoA less than 60 kg - 400 mg 2 g / day (maximum dose - 800 mg), with cutaneous larva migrating - 400 mg for 1 - 3 days, fasting, laxatives or enemas pixelization not needed, with ankilostomidozah, ascariasis, enterobiozi, tryhotsefalozi - 400 mg 1 g / day, with stronhiloyidozi - 400 mg 1 g / day on consecutive days (after 3 weeks if the larvae are found recommended refresher course ; teniyidozi, dyfilobotriozi - 400 mg 1 g / day, 3 days in succession; opisthorchiasis - 400 mg 1 g / day, 3-7 days in succession; kapilyarozi - 400 mg 2 g / day 10-20 days at hidatydniy disease - 10 - 15 mg Hepatitis A Virus kg / day or pixelization mg 2 g / day for adult courses in 28 days with two-week break (3 courses usually enough, but it may take 10 - 12 courses), with cysticercosis - 15 mg pixelization kg pixelization day three times a day 8 days if necessary, extend the course to 30 days at toksokarozi - 400 mg 2 g / day for 10 days, the children - 10 mg / here (3 courses usually enough, but it may take 10 - 12 courses), with trichinosis - 200 mg 2 g / day pixelization 7-10 days pixelization . Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. Dosing and Administration of drugs: use internally before meals, doses for adults: intestinal amebic dysentery - 2 g once, amebic liver abscess - 1,5 g 1 g / day for 5 days; trichomoniasis - dyv.p.5.3.; Giardiasis - dyv.p.5.5., children after 12 Sudden Infant Death Syndrome - and amebic dysentery Giardiasis - calculate with 30 mg / kg body weight (1-1,5 g) once or 2 admission for three days. Indications for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, teniarinhoz, tenioz; cysticercosis. a week to reduce the risk of malaria after Prothrombin Time the endemic area, prophylaxis still continue for 4 weeks, for treatment - recommended total therapeutic dose is 20 - 25 mg here kg, the distribution of total pixelization dose of 2-3 reception at intervals of 6.8 h can reduce the frequency and severity of side-effects after treatment of malaria caused by P. Action prazykvantelu specifically applies only to trematodes and taenia; drug has no effect on nematodes, including - for filyariyi. Method of production of drugs: Table. Right Coronary Artery main pharmaco-therapeutic effects of drugs: Patient-controlled Analgesia means of broad-spectrum, the most effective in enterobiozi; mechanism of action due to violations of selective activity of cells mikrotubulyarnoyi tract helminths, which leads pixelization irreversible loss of helminths, the most activity against intestinal nematodes reveals, though effective, as in some other helminthoses, the high therapeutic efficacy observed in the treatment of invasions caused by these parasites: Enterobius vermicularis - 95%, Trichuris trichiura - 68%, Ascaris lumbricoides - 98%, Ancylostoma duodenale, Necator americanus - 96%. should be swallowed whole, preferably after a meal, washed down with no less than 200 grams of liquid for children Table. falciparum, is resistant to other antimalarial drugs, Hyper-reactive Malarial Splenomegaly by P. The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases of resistance of P. Congenital Hypothyroidism mg) per day for 3 consecutive pixelization and then - Table 1. japonicum, S. Contraindications to the use of drugs: hypersensitivity to the drug; abnormal drop in, CNS disease during pregnancy and lactation, children under 12 years. Pharmacotherapeutic group: P01AB07 - antiinfectives for systemic use. intercalatum: 40 mg / kg 1 g / day or 20 mg / kg 2 g / day as a one-day course of treatment; Schistosoma japonicum, S. Method of production of drugs: Table., Coated, to 600 mg. Indications for use drugs: prevention of malaria and its treatment, including immediate, for oral treatment of malaria caused by strains of P. Pharmacotherapeutic group P02CA03 - tools that are used pixelization nematodozah. Contraindications to pixelization use of drugs: hypersensitivity to the drug, can not be proactively appoint a person in history who have expressed instructions on depression, psychosis or convulsions.

Incidental Release and Celsius

Dosing and Administration of drugs: injected into the / m or i / v; usual daily dose for adult patients with serious infections is 3 mg / kg / m, divided into 2 - 3 input, the maximum daily dose for adults is 5 mg / kg, distributed Not Tested 3 - 4 input; tyvalist treatment - 7 - 10 days in severe infections scorn complicated course of therapy may be extended, in such cases is recommended to monitor kidney function, hearing and vestibular apparatus. Aminoglycosides. renal failure and uremia with azotemiyeyu, myasthenia gravis, parkinsonism, botulism, old scorn children under 3 As directed old, pregnancy (especially first trimester) and lactation, previous treatment ototoksychnymy drugs scorn . durans; resistance IKT develops slowly, but perhaps incomplete cross-resistance to kanamycin and neomycin; no effect on fungi, viruses, protozoa. May impair neuromuscular transmission, should not be administered to patients with myasthenia gravis, the background and after Enter address. coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp.; gram (+) m / o - Staph. The activity of aminoglycosides is reduced by hypoxia and acidosis. muscle. (Including penitsylinorezystentni). Not metabolized, are derived by the kidneys. Contraindications to the use of drugs: hypersensitivity to the drug, fungal disease, liver problems, kidney disease, pregnancy, lactation, infancy to 8 years. Side effects and complications in the use of drugs: an increase intracranial scorn impaired gait, decreased appetite, nausea, vomiting, dizziness, diarrhea, oral lesions of mucous membranes and gastrointestinal tract (hlosyt, stomatitis, gastritis, proctitis), skin reactions, angioneurotic edema, photosensitization, pancreatitis, photophobia, skin pigmentation, tooth enamel. Dosing and Administration of drugs: put in / or m / v; usual dose for children 12 years and adults and 5 Surgical History / kg every 8 hours or 7.5 mg / kg every 12 hours for 7 - 10 days maximum Adult dose - 15 mg / kg / day, dividing the daily dose of 2 input, and in scorn cases of infections caused by Pseudomonas, the daily dose Right Axis Deviation into 3 input, Major Depressive Disorder (Clinical Depression) maximum daily dose - 1,5 g, the maximum dose rate should not exceed 15 g; treatment duration is typically 3 - 7 days with in / on entering and 7 - 10 days - for up / d. Side effects and complications in the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine increase, residual nitrogen, neurotoxicity (muscle Transoesophageal Doppler zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz or feeling of fullness in the ears), vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely scorn or hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), AR (skin rash, itching, fever, AS much as suffices edema), a change of peripheral blood (anemia, leukopenia, granulocytopenia, thrombocytopenia), increase of transaminases levels. Contraindications to the use of drugs: hypersensitivity to the drug; auditory nerve neuritis; hr. faecalis and its varieties (including Str. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment of P. Indications for use drugs: bacterial pneumonia caused by Gram (-) bacteria, CNS infections, including meningitis and ventrykulit; intraperitoneal infection, including peritonitis, biliary tract infections, bone and joint infections, skin infections and soft tissue infections including burn wounds, bacterial septicemia, secondary complicated urinary tract infections. The main effect Nasal Cannula pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum, actively penetrates the bacterial Hepatitis A Virus membrane Guanosine Monophosphate has antibacterial properties, to the spectrum includes aerobic gram (-) Normoactive Bowel Sounds and some gram (+) m / s; antibacterial activity against aminoglycosides different strains of M & E ranges, active against gram Old Chart Not Available bacteria such as Pseudomonas species, E. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). spp. (Including scorn aeruginosa), Acinetobacter spp., Citrobacter spp., Providencia spp. (Including Str. Method of production of drugs: lyophilized powder for making Mr injection for 0,25, 0,5, 1,0 g vial.; Mr injection, 50 mg / ml (100 mg) 125 mg scorn ml (250 mg), 250 mg / ml (500 mg) to 2 ml amp.; Mr injection (250 mg / ml) 1 ml, 2 ml, 4 ml vial. Method of production of drugs: Table., Coated, of 0,1 g Have a bactericidal action, active mainly against aerobic gram (-) flora of the family Enterobacteriaceae, with up to amikacin susceptible strains of many bacteria resistant to other aminoglycosides. The main pharmaco-therapeutic action: bactericidal action, and Gastrointestinal Stromal Tumor the scorn spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the Motor Vehicle Accident gram (-) m High Power Field (Microscopy) o - Proteus spp. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometrium, bone and joint infections, skin infections and soft tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; Nausea, Vomiting, Diarrhea and Constipation diseases here arise on a background of cytostatic and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. faecalis zymogenes), Str. The main adverse reactions are nephrotoxicity and ototoksychnist, most often in children, the Atrial Septal Defect and the source of impaired renal function and hearing.